Published in Tumori on June 11, 2007
Causes of death among lead smelters in relation to the glucose-6-phosphate dehydrogenase polymorphism. Occup Environ Med (2006) 0.75
Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med (2012) 5.87
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc Natl Acad Sci U S A (2008) 5.27
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00. J Clin Oncol (2010) 1.77
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood (2013) 1.68
Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study. Blood (2009) 1.65
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance. Blood (2011) 1.59
New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood (2004) 1.51
Reproducibility of liver iron concentration measured on a biopsy sample: a validation study in vivo. Am J Hematol (2014) 1.44
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood (2010) 1.34
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica (2009) 1.28
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. Clin Cancer Res (2009) 1.21
Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. Haematologica (2008) 1.19
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. Blood (2014) 1.19
Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood (2010) 1.17
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study. Haematologica (2009) 1.15
High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program. Haematologica (2013) 1.12
Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Haematologica (2009) 1.10
Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670). Eur J Haematol (2007) 1.07
Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation. Ann Intern Med (2002) 1.06
CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease. Haematologica (2011) 1.05
Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy. Haematologica (2008) 1.04
New strategies in the treatment of the thalassemias. Annu Rev Med (2005) 1.03
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia. Haematologica (2007) 0.99
Allogeneic stem cell transplantation for thalassemia major. Haematologica (2008) 0.95
Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma. Am J Hematol (2004) 0.94
Risk of malignant lymphoma following viral hepatitis infection. Int J Hematol (2008) 0.94
Dissecting the genetic make-up of North-East Sardinia using a large set of haploid and autosomal markers. Eur J Hum Genet (2012) 0.94
Bannayan-Riley-Ruvalcaba syndrome with reactive nodular lymphoid hyperplasia and autism and a PTEN mutation. Am J Med Genet A (2006) 0.94
Perivascular epithelioid cell (PEC) tumors of the uterus: a clinicopathologic study of two cases with aggressive features. Mod Pathol (2005) 0.94
Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol (2004) 0.93
Anemia in beta-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression. Haematologica (2008) 0.93
HLA-DQB1*0201 homozygosis predisposes to severe intestinal damage in celiac disease. Scand J Gastroenterol (2007) 0.93
Cancer mortality among men occupationally exposed to dichlorodiphenyltrichloroethane. Cancer Res (2005) 0.91
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population. BMC Cancer (2009) 0.90
Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia. Cancer Res (2010) 0.89
HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target. Clin Cancer Res (2013) 0.87
Job strain, hypoxia and risk of amyotrophic lateral sclerosis: Results from a death certificate study. Amyotroph Lateral Scler (2010) 0.85
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial. Haematologica (2005) 0.85
Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia. Hematol Oncol (2008) 0.84
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes. Br J Haematol (2014) 0.84
Reproductive outcomes in DDT applicators. Environ Res (2005) 0.84
New analytical tools and epidemiological data for the identification of HbA2 borderline subjects in the screening for beta-thalassemia. Bioelectrochemistry (2008) 0.84
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients. J Pathol (2012) 0.84
Newly diagnosed cases of hematologic malignancies in Sardinia in the early 2000: an estimation of their number, age and geographic distribution on the basis of a previous epidemiologic survey. Haematologica (2005) 0.82
Efficacy of a "Rescue" Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment Failures. Gastroenterol Res Pract (2012) 0.82
Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia. Haematologica (2013) 0.82
The role of oxidant injury in the pathophysiology of human thalassemias. Redox Rep (2003) 0.82
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. Am J Hematol (2013) 0.81
Long-term lithium treatment and survival from external causes including suicide. J Clin Psychopharmacol (2007) 0.81
Primary non-Hodgkin's lymphoma of the breast: a report of 11 cases. Haematologica (2004) 0.81
Household contact with pets and birds and risk of lymphoma. Cancer Causes Control (2010) 0.80
Unexpected CNS localization in M2 acute myeloid leukemia: a link with past heroin addiction? Am J Hematol (2008) 0.80
Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox. Leuk Res (2011) 0.80
Treatment of hepatitis C in patients with thalassemia. Haematologica (2008) 0.80
Molecular characterization of alpha-thalassemia in Pakistan. Hemoglobin (2003) 0.80
Identification of a founder BRCA2 mutation in Sardinian breast cancer families. Fam Cancer (2007) 0.80
High sensitivity of reverse-hybridization methodology in the detection of KRAS mutations from formalin-fixed paraffin-embedded colorectal cancer samples. Diagn Mol Pathol (2010) 0.79
Serum sex hormones in men occupationally exposed to dichloro-diphenyl-trichloro ethane (DDT) as young adults. J Endocrinol (2004) 0.78
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients. Am J Hematol (2012) 0.78
Tyrosine kinase receptor status in endometrial stromal sarcoma: an immunohistochemical and genetic-molecular analysis. Int J Gynecol Pathol (2012) 0.78
Lymphoma risk in livestock farmers: results of the Epilymph study. Int J Cancer (2012) 0.78
The evolving clinical scenario of myelodysplastic syndrome: the need for a complete and up to date upfront diagnostic assessment. Eur J Intern Med (2010) 0.78
S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma. Am J Surg Pathol (2009) 0.77
Effect of urban traffic, individual habits, and genetic polymorphisms on background urinary 1-hydroxypyrene excretion. Ann Epidemiol (2006) 0.77
Reproductive outcomes following environmental exposure to DDT. Reprod Toxicol (2006) 0.77
Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients. Am J Hematol (2008) 0.77
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation. Ann Hematol (2013) 0.76
Reduced Left Ventricular Contractile Reserve Identified by Low Dose Dobutamine Echocardiography as an Early Marker of Cardiac Involvement in Asymptomatic Patients with Thalassemia Major. Echocardiography (1996) 0.76
Another Step Forward in Iron Chelation Therapy. Acta Haematol (2015) 0.76
Patients with early-stage myelodysplastic syndromes show increased frequency of CD4+CD25+CD127(low) regulatory T cells. Acta Haematol (2012) 0.76
High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy. Clin Chem Lab Med (2004) 0.75
Patterns of iron distribution in liver cells in beta-thalassemia studied by X-ray microanalysis. Haematologica (2002) 0.75
Causes of death among lead smelters in relation to the glucose-6-phosphate dehydrogenase polymorphism. Occup Environ Med (2006) 0.75
Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre study. Ann Hematol (2011) 0.75
Cardiogenic Shock during First Infusion of Anthracycline Chemotherapy in a Patient with Hodgkin Lymphoma: An Unusual Event. Cardiology (2017) 0.75
Iron overload, cardiac iron loading and function in myelodysplastic syndrome. Leuk Res (2009) 0.75
Marginal zone B-cell lymphoma arising in donor cells in a Hepatitis-C virus infected patient over 20 years after allogeneic bone marrow transplantation. Leuk Lymphoma (2008) 0.75
Sudden cardiac failure in a beta-thalassemia major patient receiving chemotherapy for acute promyelocytic leukemia. Leuk Lymphoma (2007) 0.75
Lipid peroxidation in plasma of rats treated with ferric-nitrilotriacetate, in relation to kidney and liver modifications. Biofactors (2005) 0.75
Do matrix metalloproteinase-1 and glucose-6-phosphate dehydrogenase gene polymorphisms interact in promoting lymphoma development? Leuk Lymphoma (2013) 0.75
A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma. Hematol Oncol (2010) 0.75